BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,000 | – | 1,355 | +594.9% | 0.00% | – |
| Q1 2023 | $0 | – | 195 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 195 | -47.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 371 | -46.6% | 0.00% | – |
| Q2 2022 | $1,000 | -80.0% | 695 | -60.8% | 0.00% | – |
| Q1 2022 | $5,000 | -81.5% | 1,771 | -64.5% | 0.00% | – |
| Q4 2021 | $27,000 | +28.6% | 4,986 | +99.9% | 0.00% | – |
| Q3 2021 | $21,000 | +10.5% | 2,494 | +60.0% | 0.00% | – |
| Q2 2021 | $19,000 | -44.1% | 1,559 | +11.8% | 0.00% | – |
| Q1 2021 | $34,000 | +161.5% | 1,394 | +253.8% | 0.00% | – |
| Q4 2020 | $13,000 | +1200.0% | 394 | +2217.6% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 17 | -39.3% | 0.00% | – |
| Q2 2020 | $1,000 | -91.7% | 28 | -94.3% | 0.00% | – |
| Q1 2020 | $12,000 | – | 487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |